Yahoo Finance26d
Aspire Biopharma Holdings, Inc., to Launch the Next Generation of Pre-Workout Performance Supplement
"We are excited about the opportunity to leverage our delivery technology into the very large and growing pre-workout supplement market," commented Kraig Higginson, Chief Executive Officer of Aspire.
Business Insider16d
Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform
and scalable way to produce a new therapeutic sublingual form of aspirin," commented Kraig Higginson, Chief Executive Officer of Aspire. "We believe that our technology has the potential to transform ...
Charlotte Observer16d
Aspire Biopharma Holdings, Inc., Provides Update on Recently Filed U.S. Patent Applications for Its Sublingual Drug Delivery Platform
and scalable way to produce a new therapeutic sublingual form of aspirin," commented Kraig Higginson, Chief Executive Officer of Aspire. "We believe that our technology has the potential to ...